147 related articles for article (PubMed ID: 28654115)
1. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.
Xu J; Church SJ; Patassini S; Begley P; Waldvogel HJ; Curtis MA; Faull RLM; Unwin RD; Cooper GJS
Metallomics; 2017 Aug; 9(8):1106-1119. PubMed ID: 28654115
[TBL] [Abstract][Full Text] [Related]
2. Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.
Xu J; Begley P; Church SJ; Patassini S; McHarg S; Kureishy N; Hollywood KA; Waldvogel HJ; Liu H; Zhang S; Lin W; Herholz K; Turner C; Synek BJ; Curtis MA; Rivers-Auty J; Lawrence CB; Kellett KA; Hooper NM; Vardy ER; Wu D; Unwin RD; Faull RL; Dowsey AW; Cooper GJ
Sci Rep; 2016 Jun; 6():27524. PubMed ID: 27276998
[TBL] [Abstract][Full Text] [Related]
3. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
[TBL] [Abstract][Full Text] [Related]
4. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
[TBL] [Abstract][Full Text] [Related]
5. Evidence that levels of nine essential metals in post-mortem human-Alzheimer's-brain and ex vivo rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location.
Scholefield M; Church SJ; Xu J; Kassab S; Gardiner NJ; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
Metallomics; 2020 Jun; 12(6):952-962. PubMed ID: 32373908
[TBL] [Abstract][Full Text] [Related]
6. Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease.
Xu J; Patassini S; Begley P; Church S; Waldvogel HJ; Faull RLM; Unwin RD; Cooper GJS
Biochem Biophys Res Commun; 2020 Jun; 527(3):676-681. PubMed ID: 32416962
[TBL] [Abstract][Full Text] [Related]
7. Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.
Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
Front Aging Neurosci; 2021; 13():641222. PubMed ID: 33746735
[TBL] [Abstract][Full Text] [Related]
8. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.
Szabo ST; Harry GJ; Hayden KM; Szabo DT; Birnbaum L
Toxicol Sci; 2016 Apr; 150(2):292-300. PubMed ID: 26721301
[TBL] [Abstract][Full Text] [Related]
10. Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain.
Srivastava RA; Jain JC
J Neurol Sci; 2002 Apr; 196(1-2):45-52. PubMed ID: 11959156
[TBL] [Abstract][Full Text] [Related]
11. Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia.
Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
Front Mol Neurosci; 2021; 14():711396. PubMed ID: 34751215
[TBL] [Abstract][Full Text] [Related]
12. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process.
Schonberger SJ; Edgar PF; Kydd R; Faull RL; Cooper GJ
Proteomics; 2001 Dec; 1(12):1519-28. PubMed ID: 11747211
[TBL] [Abstract][Full Text] [Related]
14. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
[TBL] [Abstract][Full Text] [Related]
15. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.
Han X; Holtzman DM; McKeel DW
J Neurochem; 2001 May; 77(4):1168-80. PubMed ID: 11359882
[TBL] [Abstract][Full Text] [Related]
16. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
17. Elevated hippocampal copper in cases of type 2 diabetes.
Philbert SA; Schönberger SJ; Xu J; Church SJ; Unwin RD; Cooper GJS
EBioMedicine; 2022 Dec; 86():104317. PubMed ID: 36335667
[TBL] [Abstract][Full Text] [Related]
18. Widespread severe cerebral elevations of haptoglobin and haemopexin in sporadic Alzheimer's disease: Evidence for a pervasive microvasculopathy.
Philbert SA; Xu J; Unwin RD; Dowsey AW; Cooper GJS
Biochem Biophys Res Commun; 2021 May; 555():89-94. PubMed ID: 33813281
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer's disease patients.
Davis JD; Podolanczuk A; Donahue JE; Stopa E; Hennessey JV; Luo LG; Lim YP; Stern RA
Curr Aging Sci; 2008 Dec; 1(3):175-81. PubMed ID: 20021390
[TBL] [Abstract][Full Text] [Related]
20. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry.
Panayi AE; Spyrou NM; Iversen BS; White MA; Part P
J Neurol Sci; 2002 Mar; 195(1):1-10. PubMed ID: 11867068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
